News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Karyopharm Therapeutics Announces Appointment of Paul Brannelly as Senior Vice President of Finance and Administration



6/13/2013 8:51:39 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NATICK, Mass., June 13, 2013 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc., a leader in the new field of nuclear transport modulators, today announced that Paul Brannelly has joined the company as Senior Vice President, Finance and Administration. Mr. Brannelly brings over 13 years of experience in senior management roles leading growth-oriented biopharmaceutical companies through private and public financings, mergers and acquisitions and general financial operations. In this role at Karyopharm, Mr. Brannelly will be responsible for leading and managing all of the company's finance activities and will be a member of the management team.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES